Role of N6-methyladenosine Modification in Cardiac Remodeling

Area of Science:

• Cardiovascular Biology
• Molecular Biology
• Epigenetics

Background:

• Cardiac remodeling is a key process in heart failure, often inadequately treated.
• Epitranscriptomic modifications, including m6A methylation, are prevalent in cardiac remodeling.
• Long non-coding RNAs (lncRNAs) are implicated in cardiac remodeling and heart failure pathophysiology.

Purpose of the Study:

• To review the current understanding of m6A modification's role in cardiac remodeling.
• To explore the interplay between lncRNAs and m6A modification in cardiac disease.
• To identify potential regulatory mechanisms and therapeutic targets.

Main Methods:

• Literature review of current research on m6A modification in cardiac remodeling.
• Analysis of studies investigating lncRNAs in heart failure.
• Synthesis of findings on the crosstalk between m6A and lncRNAs.

Main Results:

• Dysregulation of m6A modification is observed in various cardiac diseases.
• The specific functions of m6A modifications in cardiac remodeling are not fully elucidated.
• The interaction between lncRNAs and m6A presents a promising area for mechanistic and therapeutic exploration.

Conclusions:

• m6A modification is a significant factor in cardiac remodeling.
• Further research into m6A and lncRNA interactions is crucial for developing novel heart failure treatments.